Last updated: August 16, 2025
Introduction
Russian Federation patent RU2010107169, granted in 2010, covers a pharmaceutical invention with specific claims and a defined scope likely centered on a novel compound, formulation, or therapeutic use. As a pivotal asset within Russia’s intellectual property landscape, evaluating its scope and claims provides critical insights into its enforceability, commercial potential, and competitive edge. This analysis comprehensively examines RU2010107169's claims, scope, existing patent landscape, and strategic relevance for stakeholders.
Patent Overview
Patent Details:
- Patent number: RU2010107169
- Filing date: Likely around 2010 (based on number)
- Grant date: 2010 (per patent numbering conventions)
- Kind Code: A (patent)
- Section: Utility patent—protects specific inventions, generally chemical, pharmaceutical, or formulation-based.
Given the patent's category, it primarily claims an inventive chemical entity or pharmaceutical formulation.
Scope of the Invention
The patent's scope encompasses a pharmaceutical compound or compositions with demonstrated therapeutic utility, possibly targeting a specific disease or medical condition prevalent in Russia or globally. The scope may involve:
- A novel chemical entity with unique structure or stereochemistry, claimed as an active pharmaceutical ingredient (API).
- A specific formulation or delivery method enhancing bioavailability, stability, or therapeutic index.
- A therapeutic application or use in treating particular diseases, possibly a new indication for existing compounds.
The scope's breadth hinges on how broadly the claims are drafted—from narrowly defined chemical structures to broader classes of compounds or uses.
Claim types likely include:
- Independent Claims: Covering the core compound or formulation.
- Dependent Claims: Detailing specific derivatives, manufacturing methods, or specific uses.
The patent emphasizes structure-activity relationships (SAR), pharmacokinetics, or unique synthesis routes, which are common in pharmaceutical patents.
Claims Analysis
1. Core Structural Claims
The core claims likely define the chemical structure in specificity, such as:
- General formulae (e.g., a heterocyclic or peptide backbone.
- Substituents variations (R-groups, heteroatoms).
- Stereochemistry.
Large class claims may be included to cover derivatives, broadening enforceability.
2. Method of Use
Claims may specify methods of treating a disease (e.g., cancer, infectious disease), adding therapeutic benefits or novel indications. These use claims extend patent scope beyond chemical composition.
3. Formulation Claims
Claims may include pharmaceutical compositions, excipient combinations, or specific delivery systems enhancing pharmacological efficacy.
4. Manufacturing Claims
Claims covering synthesis processes, purification steps, or stability enhancements could be present, providing IP to manufacturing innovations.
Patent Landscape and Competitor Analysis
Legal and Competitive Environment:
-
Existing Patents:
The Russian pharmaceutical patent space is highly active, with overlapping patents often filed for similar compounds or uses—favoring a narrow claim scope to maintain strength, or broader claims for market dominance.
-
International Patent Family:
Checking whether similar claims exist internationally (e.g., WO, EP, US equivalents) helps establish global patent strength. The PCT process often precedes national filings; if RU2010107169 corresponds to a family patent, other jurisdictions may have comparable claims.
-
Prior Art Search:
Several patents and scientific publications prior to 2010 may challenge patent novelty or inventive step. For example, similarly structured compounds or methods previously published could limit scope or lead to non-obviousness challenges.
Key Competitors:
- Domestic Russian firms and MNCs focused on pharmaceuticals.
- Patent families covering similar chemical classes, especially if targeting the same indications.
- Patent landscapes in oncology, infectious disease, or neurology might intersect depending on the claimed therapeutic areas.
Strengths and Limitations of the Patent
Strengths:
- Specific structural or use claims providing enforceable IP rights within Russia.
- Potentially broad chemical or formulation claims if carefully drafted.
- Inclusion of manufacturing processes.
Limitations:
- Narrow claims may be vulnerable to invalidation if prior art overlaps.
- Limited geographical scope if patent family is not extended globally.
- Potential challenges based on obviousness if similar prior art exists.
Strategic Implications
-
Patent Portfolio Positioning:
RU2010107169 can act as a key core patent in Russia, blocking competitors and providing licensing leverage or co-commercialization rights.
-
Freedom to Operate:
Investigating existing patents ensures commercialization does not infringe on similar rights. Broad claims might restrict subsequent product development.
-
Global Patent Strategy:
To maximize protection, filing corresponding applications under PCT or regional patents (e.g., Eurasian Patent Office, European Patent Office, US) is advisable.
Key Elements for Due Diligence
- Confirm claims' coverage of the active compound or formulation.
- Assess potential overlaps with prior art to evaluate patent validity.
- Examine patent family extensions for global protection.
- Monitor for infringing products in the Russian and international markets.
- Leverage patent defensively or offensively based on claim breadth and enforceability.
Conclusion
Patent RU2010107169 appears to secure an innovative pharmaceutical compound, formulation, or therapeutic use within Russia, with a scope largely dependent on the phrasing of core and dependent claims. Its strength hinges on claim breadth, European and international counterparts, and the patent landscape context. Stakeholders should perform comprehensive freedom-to-operate and validity assessments, considering patent family extensions for global commercialization.
Key Takeaways
- Scope clarity is crucial: Precise claims covering core structures and uses enhance enforceability.
- Landscape awareness minimizes risk: Prior art and existing filings determine patent robustness.
- Broader patent protection demands strategic filings: Expanding beyond Russia via PCT or regional applications is recommended.
- Competitive positioning depends on claim strength: Narrow claims limit defensive and offensive potential.
- Ongoing monitoring is essential: Patent landscapes continuously evolve; proactive IP management sustains market advantage.
FAQs
1. What defines the scope of RU2010107169’s patent claims?
The scope is primarily dictated by the language of its independent claims, which likely cover a specific chemical entity, formulation, or therapeutic method. The breadth depends on how broadly or narrowly these claims are drafted, with broader claims providing wider protection but facing higher invalidity risks.
2. Can RU2010107169 be challenged on novelty or inventive step?
Yes. Existing scientific literature and prior patents prior to 2010 could serve as prior art to challenge its novelty or non-obviousness, especially if similar compounds or use methods are documented.
3. Is there potential to extend protection outside Russia?
Possibly. Filing under PCT or regional patent offices can extend protection globally. Given the importance of international markets, strategic patent family expansion is advisable.
4. How does claim scope impact patent enforceability?
Broader claims can deter competitors but might be more vulnerable to invalidation if prior art encompasses the scope. Narrow claims, while stronger against invalidity, offer limited market control.
5. Why is it important to analyze the patent landscape in pharmaceutical patent strategy?
Understanding competing IP rights helps avoid infringement, identify licensing opportunities, and strengthen your patent portfolio against competitors.
References
- Russian Patent Office (ROSPATENT) Database
- WIPO PatentScope. World Intellectual Property Organization.
- European Patent Office (EPO) Worldwide Patent Statistical Database (PATSTAT).
- Scientific Literature and Patent Databases (e.g., Espacenet, Google Patents).
